Dame Kate Bingham on Healthcare VC, Biotech & Leading the UK's COVID-19 Vaccine Taskforce

episode

Previously titled “80: Dame Kate Bingham on Healthcare VC, Biotech & Leading the UK's COVID-19 Vaccine Taskforce” — renamed by the publisher on Aug 6, 2026

Money Maze Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

NPR News: 09-28-2026 7PM EDT 5 min · 28 Sep 2026 · NPR News Now

‘Star Wars’ Announces Another Chapter of the Skywalker Saga. Plus, ‘Lioness’ Season 3 Finale With Van Lathan. 1h 11m · 28 Sep 2026 · The Watch

H4 Matt Derrick 47 min · 28 Sep 2026 · The Program

Trump’s War on Canada ESCALATES as New Bans Take Effect 45 min · 28 Sep 2026 · Raging Moderates with Scott Galloway and Jessica Tarlov

Oilers Legend Craig MacTavish (9/28/26) 18 min · 28 Sep 2026 · Oilers NOW with Bob Stauffer

7PM ET 09/28/2026 Newscast 3 min · 28 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded17 Nov 2022

Publisheraudioboom.com ↗

Handlerec:11180878

Show notes

In the first episode of our 4-part Venture Capital Miniseries, we are thrilled to feature Dame Kate Bingham, Managing Partner of SV Health Investors and former Chair of the UK Vaccine Taskforce. The much anticipated interview begins with a high level overview of the immense changes that are taking place in the world of medical research which have allowed us to move from treating symptoms to changing the way the body works. Kate describes the various leaps forward across medical conditions and the role SV Health Investors is playing to facilitate this. She discusses their approach, challenges, opportunities and the skills needed to improve the odds of success. She then talks about research excellence, the hurdles in building large biotech enterprises and what the future industry landscape may look like. The conversation then switches to her role as Chair of the Vaccine Taskforce, set up in April 2020 under Boris Johnson to co-ordinate the creation and distribution of a COVID-19 vaccine (both in the UK and internationally). She reflects on the obstacles encountered and path to the successful execution of the group’s objectives. Sign up to our newsletter for more in-depth insights | Follow us on LinkedIn The Money Maze Podcast is kindly sponsored by Schroders, Bremont Watches, LiveTrade and Mintus.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related